What is the diagnosis and management for an elderly patient with severe tophaceous gout, presenting with body weakness, painful tophi, decubitus ulcers, and decreasing sensorium, who has persistent fever despite meropenem, acute kidney injury, and multiple electrolyte imbalances?

Complete Diagnosis and Management for Elderly Patient with Severe Tophaceous Gout and Multi-Organ Complications

Primary Diagnosis

This patient has severe debilitating chronic tophaceous gout with multiple life-threatening complications: sepsis from infected ruptured tophi (Proteus mirabilis), acute kidney injury with uremia requiring hemodialysis, altered mental status (uremic encephalopathy vs. septic encephalopathy), and severe pressure ulcers with immobility. 1

Complete Diagnostic List (in order of priority):

1. Sepsis secondary to infected ruptured tophaceous gout (Proteus mirabilis on wound culture) 1
2. Severe debilitating chronic tophaceous gout with multiple infected tophi on hands and feet 1
3. Acute kidney injury with uremia requiring hemodialysis 2
4. Uremic/septic encephalopathy (altered sensorium) 3
5. Multiple stage III-IV pressure ulcers (sacral area and back) with immobility
6. Severe hyperuricemia (contributing to AKI and gout severity) 1
7. Multiple electrolyte imbalances: hypernatremia, hypokalemia, hypocalcemia, hypomagnesemia 4, 5
8. Persistent fever despite broad-spectrum antibiotics (possible inadequate source control)

Lacking Diagnostics (Order Immediately)

Critical Missing Studies:

• Repeat blood cultures (at least 2 sets from different sites) - persistent fever despite meropenem suggests inadequate source control or resistant organism 2
• Wound cultures from ALL infected tophi sites (not just one) - need comprehensive microbiology to guide therapy 1
• MRI brain with contrast - unremarkable CT does not exclude encephalitis, abscess, or uremic encephalopathy complications; altered sensorium after 3 HD sessions is concerning 3
• Serum uric acid level - essential for monitoring severe tophaceous gout and guiding urate-lowering therapy 1
• Procalcitonin and CRP - to assess sepsis severity and response to antibiotics 2
• Echocardiogram - to exclude endocarditis given persistent fever and bacteremia risk 3
• Deep tissue biopsy from infected tophi - for culture, sensitivity, and histopathology to confirm infection vs. crystal inflammation 1
• Chest X-ray - to exclude aspiration pneumonia or other pulmonary source given immobility 2
• Urinalysis with microscopy - assess for pyuria, crystals, and renal involvement 2
• Serum albumin and nutritional markers - critical for wound healing and prognosis 3

Additional Laboratory Monitoring:

• Daily electrolytes (Na, K, Ca, Mg, PO4) - multiple imbalances require close monitoring during HD 5
• Meropenem trough levels - ensure adequate dosing in HD patient 6
• Parathyroid hormone (PTH) and vitamin D - hypocalcemia may be multifactorial 4

Management Plan

A. Immediate Life-Threatening Issues (First 24 Hours)

1. Sepsis Management

• Continue meropenem BUT adjust dose for hemodialysis: 1g IV after each HD session (meropenem is 50% removed by HD) 6
• Add vancomycin 1g IV after each HD session - empiric MRSA coverage for skin/soft tissue infection until cultures finalize 6
• Surgical consultation URGENT - infected ruptured tophi require debridement for source control; medical therapy alone is insufficient 1
• Infectious disease consultation - persistent fever despite meropenem requires expert guidance 2

2. Acute Kidney Injury Management

• Continue hemodialysis - 3 sessions completed but uremia persists; likely needs daily HD until mental status improves 3, 2
• Avoid all nephrotoxic agents: NSAIDs absolutely contraindicated, adjust all medications for HD 1, 7
• Target ultrafiltration goals during HD to correct hypernatremia gradually (no more than 10-12 mEq/L per 24 hours to avoid osmotic demyelination) 5

3. Electrolyte Correction During Hemodialysis

• Hypernatremia: Use low-sodium dialysate (135-138 mEq/L) and correct slowly 5
• Hypokalemia: Increase dialysate potassium to 3.0-3.5 mEq/L; supplement oral KCl 20-40 mEq TID between HD sessions 5
• Hypocalcemia: Increase dialysate calcium to 3.0-3.5 mEq/L; give calcium carbonate 1000mg PO TID with meals; check ionized calcium 4, 5
• Hypomagnesemia: Magnesium sulfate 2g IV over 2 hours after HD; oral magnesium oxide 400mg BID 5

4. Altered Mental Status

• Daily neurological assessments - document GCS and focal deficits 3
• Optimize HD adequacy - may need daily sessions until uremia resolves 2
• Avoid sedating medications - no opioids, benzodiazepines unless absolutely necessary 3
• Thiamine 100mg IV daily and folate 1mg daily - nutritional support for encephalopathy 3

B. Gout-Specific Management (After Stabilization of Sepsis)

1. DO NOT Treat Acute Gout Flare in This Patient

• Colchicine is ABSOLUTELY CONTRAINDICATED: severe renal impairment (on HD) makes colchicine extremely toxic with risk of fatal neuromuscular toxicity 1, 7
• NSAIDs are ABSOLUTELY CONTRAINDICATED: AKI and HD make NSAIDs dangerous (further renal injury, bleeding risk) 1
• Corticosteroids are RELATIVELY CONTRAINDICATED: active infection (sepsis from infected tophi) is a contraindication to systemic steroids 1
• IL-1 blockers (anakinra) are CONTRAINDICATED: current infection is an absolute contraindication 1

The infected tophi are the priority - surgical debridement and antibiotics, NOT anti-inflammatory therapy for gout flare. 1

2. Urate-Lowering Therapy (ULT) - Start After Infection Controlled

• This patient has absolute indication for ULT: severe debilitating chronic tophaceous gout with poor quality of life 1
• Target serum uric acid <5 mg/dL (300 μmol/L) to facilitate crystal dissolution in severe tophaceous gout 1

DO NOT start allopurinol now - wait until infection is controlled and patient is stable (starting ULT during acute flare or infection can worsen symptoms) 1

When ready to start (after infection resolved, approximately 2-4 weeks):

• Allopurinol 50mg daily (start dose for HD patients) - given after HD on dialysis days 1
• Titrate slowly: increase by 50mg every 2-4 weeks, monitoring serum urate monthly 1
• Maximum dose in HD patients: 300mg daily (adjust based on urate levels and tolerability) 1
• Alternative if allopurinol fails or not tolerated: Febuxostat 40mg daily (does not require dose adjustment in renal failure) 1
• Consider pegloticase if oral ULT fails - this patient meets criteria (severe debilitating tophaceous gout, poor quality of life) 1

3. Prophylaxis Against Gout Flares

• CANNOT use colchicine - contraindicated in severe renal impairment/HD 1, 7
• CANNOT use NSAIDs - contraindicated in AKI/HD 1
• Use low-dose prednisone 5-10mg daily ONLY after infection is completely resolved and wounds are healing 1
• Duration: Continue prophylaxis for 6 months after starting ULT or until tophi resolve 1

C. Pressure Ulcer Management

1. Wound Care

• Plastic surgery/wound care consultation - stage III-IV ulcers require specialized management 2
• Surgical debridement of necrotic tissue from pressure ulcers 2
• Negative pressure wound therapy (wound VAC) for deep ulcers after debridement
• Daily dressing changes with appropriate antimicrobial dressings
• Nutritional support: protein 1.5-2.0 g/kg/day, vitamin C 500mg BID, zinc 220mg daily 3

2. Pressure Relief

• Specialty mattress (low air loss or alternating pressure) - essential for healing 2
• Turn every 2 hours - document positioning schedule
• Physical therapy consultation - early mobilization as tolerated to prevent further deconditioning

D. Supportive Care

1. Nutrition

• Dietitian consultation - HD patients need specialized diet 2
• High protein diet (1.2-1.5 g/kg/day on HD days) for wound healing 3
• Restrict potassium, phosphorus as needed based on labs 5
• Gout-specific dietary advice (when stable): avoid alcohol, sugar-sweetened drinks, excessive meat/seafood; encourage low-fat dairy 1

2. Prophylaxis

• DVT prophylaxis: enoxaparin 30mg SC daily (renal dosing) - immobile patient at high risk 2
• Stress ulcer prophylaxis: pantoprazole 40mg IV daily 2
• Bowel regimen: docusate 100mg BID + senna PRN to prevent constipation 3

Chart Orders (Priority Order)

STAT Orders:

1. Blood cultures x2 sets from different sites
2. Wound cultures from ALL infected tophi sites (send for aerobic, anaerobic, fungal)
3. Deep tissue biopsy from infected tophus (culture + histopath)
4. MRI brain with and without contrast
5. Serum uric acid level
6. Procalcitonin, CRP
7. Ionized calcium, magnesium, phosphorus
8. Serum albumin, prealbumin
9. Chest X-ray portable
10. Echocardiogram transthoracic

Consultations (STAT):

1. General Surgery - infected tophi debridement
2. Infectious Disease - persistent fever, antibiotic optimization
3. Plastic Surgery/Wound Care - pressure ulcer management
4. Nephrology - HD optimization, electrolyte management
5. Rheumatology (non-urgent) - long-term gout management planning

Medication Orders:

1. Meropenem 1g IV after each HD session (continue current)
2. Vancomycin 1g IV after each HD session (ADD)
3. Calcium carbonate 1000mg PO TID with meals
4. Magnesium oxide 400mg PO BID
5. Potassium chloride 20 mEq PO TID (hold if K >5.0)
6. Thiamine 100mg IV daily
7. Folic acid 1mg PO daily
8. Pantoprazole 40mg IV daily
9. Enoxaparin 30mg SC daily
10. Docusate 100mg PO BID
11. Acetaminophen 650mg PO Q6H PRN pain (avoid NSAIDs)

Hemodialysis Orders:

1. Daily hemodialysis until mental status improves and uremia resolves
2. Dialysate composition: Na 135-138, K 3.0-3.5, Ca 3.0-3.5, Mg 1.0 mEq/L
3. Ultrafiltration goal: Remove excess fluid gradually, correct Na slowly
4. Post-HD weights and vital signs
5. Give meropenem and vancomycin AFTER each HD session

Monitoring Orders:

1. Vital signs Q4H (including temperature)
2. Neurological checks Q4H (GCS, pupil reactivity, focal deficits)
3. Strict intake/output
4. Daily weights
5. BMP daily (Na, K, Cl, CO2, BUN, Cr, glucose)
6. Ionized calcium, magnesium, phosphorus every other day
7. CBC with differential every other day
8. Wound assessments daily with photography
9. Blood glucose monitoring QID (AC meals + HS)

Nursing Orders:

1. Turn patient Q2H - document position changes
2. Specialty mattress (low air loss or alternating pressure)
3. Wound care per plastic surgery recommendations
4. Fall precautions (altered mental status)
5. Aspiration precautions (keep HOB elevated 30-45 degrees)

SOAP Note Format

S (Subjective):

Elderly patient with known severe tophaceous gout, currently unable to provide history due to decreased sensorium. Per family/records: presented with sudden onset body weakness, painful tophaceous gout, became bedridden with development of multiple decubitus ulcers on sacral area and back. Multiple infected ruptured tophaceous gout lesions on hands and feet. Completed 3 hemodialysis sessions without improvement in mental status. Initially required norepinephrine for hypotension, now off pressors with stable blood pressure. Persistent fever despite meropenem therapy.

O (Objective):

Vital Signs: [Insert current vitals - temperature, BP, HR, RR, O2 sat]

General: Elderly, ill-appearing, decreased level of consciousness, bedridden

HEENT: [Document mental status - GCS score]

Cardiovascular: Off pressors, blood pressure stable [insert BP]

Respiratory: [Insert findings]

Extremities:

• Multiple ruptured tophaceous gout lesions on hands and feet with purulent drainage
• Signs of infection: erythema, warmth, purulent discharge
• [Document specific locations and sizes]

Skin:

• Multiple stage III-IV pressure ulcers on sacral area and back
• [Document size, depth, presence of necrotic tissue, undermining]

Neurological: Decreased sensorium [document GCS], [document any focal deficits]

Laboratory Data:

• Renal: BUN [value], Creatinine [value], on hemodialysis
• Electrolytes: Hypernatremia [value], Hypokalemia [value], Hypocalcemia [value], Hypomagnesemia [value]
• Uric Acid: Severe hyperuricemia [value if available]
• CBC: [Insert values]
• Cultures: Wound culture positive for Proteus mirabilis; blood cultures negative after antibiotics

Imaging:

• Cranial CT: Unremarkable (initial reading)

Dialysis: Completed 3 sessions, no improvement in sensorium

A (Assessment):

1. Sepsis secondary to infected ruptured tophaceous gout (Proteus mirabilis) - inadequate source control, requires surgical debridement
2. Severe debilitating chronic tophaceous gout - multiple infected tophi, candidate for aggressive ULT after infection controlled
3. Acute kidney injury with uremia requiring hemodialysis - persistent uremia contributing to altered mental status
4. Uremic/septic encephalopathy - decreased sensorium despite 3 HD sessions, concerning for additional CNS pathology
5. Multiple stage III-IV pressure ulcers (sacral, back) - require specialized wound care and surgical debridement
6. Severe hyperuricemia - contributing to AKI and gout severity
7. Multiple electrolyte imbalances (hypernatremia, hypokalemia, hypocalcemia, hypomagnesemia) - require correction via HD and supplementation
8. Persistent fever despite meropenem - suggests inadequate source control or resistant organism

Prognosis: Guarded. Multiple life-threatening complications requiring intensive multidisciplinary management. Mortality risk high given sepsis, AKI requiring HD, altered mental status, and severe debility.

P (Plan):

Sepsis/Infection:

• Continue meropenem 1g IV after each HD session
• ADD vancomycin 1g IV after each HD session for empiric MRSA coverage
• STAT surgical consultation for debridement of infected tophi
• STAT infectious disease consultation for persistent fever
• Repeat blood cultures x2 sets, wound cultures from all infected sites
• Deep tissue biopsy from infected tophus for culture and histopathology
• Monitor procalcitonin, CRP to assess response

Acute Kidney Injury:

• Continue daily hemodialysis until uremia resolves and mental status improves
• Nephrology to optimize HD prescription
• Avoid all nephrotoxic agents (NSAIDs, contrast)
• Adjust all medications for HD
• Monitor BUN, creatinine daily

Altered Mental Status:

• MRI brain with contrast to exclude CNS infection, abscess, or other pathology
• Daily neurological assessments with GCS documentation
• Optimize HD adequacy - may need longer or more frequent sessions
• Thiamine 100mg IV daily, folic acid 1mg daily
• Avoid sedating medications

Electrolyte Management:

• Correct hypernatremia slowly via HD (low-sodium dialysate 135-138 mEq/L)
• Hypokalemia: increase dialysate K to 3.0-3.5 mEq/L, KCl 20 mEq PO TID
• Hypocalcemia: increase dialysate Ca to 3.0-3.5 mEq/L, calcium carbonate 1000mg PO TID
• Hypomagnesemia: magnesium sulfate 2g IV after HD, magnesium oxide 400mg PO BID
• Monitor electrolytes daily, adjust HD prescription accordingly

Gout Management:

• DO NOT treat acute flare now - colchicine, NSAIDs, steroids all contraindicated (severe renal impairment + active infection)
• Check serum uric acid level
• Plan to start ULT AFTER infection controlled (approximately 2-4 weeks):
  • Allopurinol 50mg daily (HD dose), titrate slowly to target uric acid <5 mg/dL
  • Cannot use colchicine or NSAIDs for flare prophylaxis; will use low-dose prednisone 5-10mg daily after infection resolved
• Rheumatology consultation for long-term gout management planning
• Dietary modifications when stable: avoid alcohol, sugar-sweetened drinks, excessive meat/seafood

Pressure Ulcers:

• STAT plastic surgery/wound care consultation
• Surgical debridement of necrotic tissue
• Specialty mattress (low air loss or alternating pressure)
• Turn Q2H with documentation
• Daily wound care with antimicrobial dressings
• Nutritional support: high protein diet (1.5-2.0 g/kg/day), vitamin C 500mg BID, zinc 220mg daily
• Physical therapy for early mobilization

Supportive Care:

• Dietitian consultation for HD-appropriate, high-protein diet
• DVT prophylaxis: enoxaparin 30mg SC daily
• Stress ulcer prophylaxis: pantoprazole 40mg IV daily
• Bowel regimen: docusate 100mg BID
• Pain control: acetaminophen 650mg Q6H PRN (avoid NSAIDs, opioids)

Monitoring:

• Vital signs Q4H including temperature
• Neurological checks Q4H (GCS, pupils, focal deficits)
• Strict I/O, daily weights
• BMP daily, ionized Ca/Mg/PO4 every other day
• CBC with differential every other day
• Wound assessments daily with photography

Disposition:

• ICU level care vs. step-down unit (depending on hemodynamic stability)
• Family meeting to discuss prognosis and goals of care
• Consider palliative care consultation given poor prognosis and severe debility

Follow-up:

• Reassess daily with team
• Surgical debridement within 24 hours
• Repeat imaging/labs as ordered
• Adjust plan based on culture results and clinical response

---

This patient requires aggressive surgical source control, optimized hemodialysis, careful electrolyte management, and staged gout therapy ONLY after infection is controlled. 1, 6, 2, 5